Development Level

Tbio 7 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

psoriasis 9 | 6,685
Cancer 7 | 2,346
osteosarcoma 7 | 7,933
ovarian cancer 7 | 8,484
invasive ductal carcinoma 6 | 2,950
pituitary cancer 6 | 1,972
cystic fibrosis 5 | 1,665
intraductal papillary-mucinous adenoma (IPMA) 5 | 2,956
lung cancer 5 | 4,466
oligodendroglioma 5 | 2,849
pilocytic astrocytoma 5 | 3,086
breast carcinoma 4 | 1,614
ductal carcinoma in situ 4 | 1,745
ependymoma 4 | 2,514
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
medulloblastoma, large-cell 4 | 6,234
non-small cell lung cancer 4 | 2,798
pancreatic cancer 4 | 2,300
sonic hedgehog group medulloblastoma 4 | 1,482
subependymal giant cell astrocytoma 4 | 2,287
Alzheimer's disease 3 | 644
Atopic dermatitis 3 | 944
Inflammation 3 | 109
Kidney disease 3 | 396
Mammary Neoplasms 3 | 410
Obesity 3 | 616
Parkinson's disease 3 | 364
atypical teratoid/rhabdoid tumor 3 | 1,095
diabetes mellitus 3 | 1,663
gastric carcinoma 3 | 832
glioblastoma 3 | 5,572
lung carcinoma 3 | 2,844
malignant mesothelioma 3 | 3,162
nasopharyngeal carcinoma 3 | 1,056
primary pancreatic ductal adenocarcinoma 3 | 1,271
primitive neuroectodermal tumor 3 | 3,031
tuberculosis 3 | 1,557
ulcerative colitis 3 | 2,087
Anemia 2 | 252
Autistic Disorder 2 | 320
Beta thalassemia 2 | 19
Brain disease 2 | 83
Breast cancer 2 | 3,094
Carcinoma 2 | 2,147
Drug-Induced Liver Injury 2 | 118
Glioma 2 | 65
Heart disease 2 | 279
Hemochromatosis 2 | 55
Hirschsprung's disease 2 | 42
Inflammatory bowel disease 2 | 142
Iron deficiency anemia 2 | 6
Iron metabolism disease 2 | 17
Lupus erythematosus 2 | 80
Malaria 2 | 140
Matthew-Wood syndrome 2 | 10
Multiple endocrine neoplasia type 2A 2 | 22
Multiple endocrine neoplasia type 2B 2 | 16
Myopia 2 | 99
Parkinsonian Disorders 2 | 23
Phyllodes Tumor 2 | 5
Pick disease 2 | 1,893
Renal agenesis 2 | 25
Thalassemia 2 | 46
active Crohn's disease 2 | 918
acute myeloid leukemia 2 | 780
adult high grade glioma 2 | 2,148
astrocytic glioma 2 | 2,241
chronic rhinosinusitis 2 | 512
colon cancer 2 | 1,475
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis and chronic rhinosinusitis 2 | 213
esophageal adenocarcinoma 2 | 737
gastric cancer 2 | 430
group 3 medulloblastoma 2 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
hepatocellular carcinoma 2 | 532
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
lung adenocarcinoma 2 | 2,713
mucosa-associated lymphoid tissue lymphoma 2 | 480
pediatric high grade glioma 2 | 2,712
posterior fossa group A ependymoma 2 | 1,511
posterior fossa group B ependymoma 2 | 1,530
primary Sjogren syndrome 2 | 789
progressive supranuclear palsy 2 | 674
spina bifida 2 | 1,064
Acne vulgaris 1 | 16
Barrett Esophagus 1 | 16
Calcinosis 1 | 62
Diarrhea 1 | 155
Echinococcosis 1 | 28
Gastrointestinal system disease 1 | 50
Human immunodeficiency virus infectious disease 1 | 92
Neoplastic Cell Transformation 1 | 81
Ocular hypotension 1 | 7
Pheochromocytoma 1 | 22
Restless legs syndrome 1 | 28
Severe Recalcitrant Psoriasis 1 | 11
Tularemia 1 | 22
Vaginal discharge 1 | 7

Tissue

Blood and immune system 10 | 17,995
Cardiovascular System 10 | 17,958
Digestive Tract 10 | 18,473
Endocrine System 10 | 18,512
Female tissues 10 | 18,647
Liver and Pancreas 10 | 18,136
Male tissues 10 | 17,969
Nervous System 10 | 18,561
Respiratory system 10 | 17,484
Skin and soft tissues 10 | 18,115
Urinary Tract 10 | 18,444

Target Family

Non-IDG 6 | 11,971
Enzyme 3 | 4,146
Nuclear Receptor 1 | 48

Grant Application

2P01DK055388-06 10 | 10
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Glial cell line-derived neurotrophic factor GDNF Tbio Non-IDG -3.30206 2301.5 303
Serotransferrin TF Tchem Non-IDG -4.13136 13124.3 952
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Retinal dehydrogenase 2 ALDH1A2 Tchem Enzyme -2.21719 171.4 208
Aldehyde dehydrogenase family 1 member A3 ALDH1A3 Tbio Enzyme -1.91605 82.9 67
Retinoic acid receptor alpha RARA Tclin Nuclear Receptor -2.94494 890.6 524
GDNF family receptor alpha-1 GFRA1 Tbio Non-IDG -2.20227 137.3 285
Filamin-A FLNA Tbio Non-IDG -3.30580 2117.1 432
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Neutrophil gelatinase-associated lipocalin LCN2 Tbio Enzyme -3.27241 2128.8 665